Roberto Bianchi
Oprichter bij BMG Pharma SpA
Momenteel actieve connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
Fausto Ferrazzi | M | - |
Serichim Srl
Serichim Srl BiotechnologyHealth Technology Serichim Srl engages in research and development of chemical synthesis methods and processes for the production of fine chemical intermediaries. The firm's services include contract research, patent analysis, feasibility studies, consultancy and technical assistance, research and environmental consultancy, fermentation, enzyme fractionation, bioprocess engineering, pilot-scale and industrial processes. The company was founded in 2006 and is headquartered in Torviscosa, Italy. | - |
Marco Mastrodonato | M | - |
BMG Pharma SpA
BMG Pharma SpA Household/Personal CareConsumer Non-Durables BMG Pharma SpA is a pharmaceutical company based in Milan, Italy. The Italian company specializes in the development and international partnership of bio-pharmaceutical products. The company focuses on the progress of oral care, dermatology, and dietary supplements. BMG Pharma is committed to sustainability, diversity, and inclusion in the workplace. BMG Pharma has developed the hyaluromimethic® technology, which they believe is a fundamental value. The company has registered 36 innovative products and launched 37 on the international market. Recently, BMG Pharma has signed an agreement with HTL Biotechnology for the production of the functional ingredient at the base of the patented hyaluromimethic®. The company was founded in 2011 by Marco Mastrodonato and Roberto Bianchi, with Marco Mastrodonato serving as the CEO since then. | 13 jaar |
Giovanni Loser | M | - |
Serichim Srl
Serichim Srl BiotechnologyHealth Technology Serichim Srl engages in research and development of chemical synthesis methods and processes for the production of fine chemical intermediaries. The firm's services include contract research, patent analysis, feasibility studies, consultancy and technical assistance, research and environmental consultancy, fermentation, enzyme fractionation, bioprocess engineering, pilot-scale and industrial processes. The company was founded in 2006 and is headquartered in Torviscosa, Italy. | - |
Diego Bravar | M | 75 |
Serichim Srl
Serichim Srl BiotechnologyHealth Technology Serichim Srl engages in research and development of chemical synthesis methods and processes for the production of fine chemical intermediaries. The firm's services include contract research, patent analysis, feasibility studies, consultancy and technical assistance, research and environmental consultancy, fermentation, enzyme fractionation, bioprocess engineering, pilot-scale and industrial processes. The company was founded in 2006 and is headquartered in Torviscosa, Italy. | - |
Edoardo Carlo Richter | M | 71 |
BMG Pharma SpA
BMG Pharma SpA Household/Personal CareConsumer Non-Durables BMG Pharma SpA is a pharmaceutical company based in Milan, Italy. The Italian company specializes in the development and international partnership of bio-pharmaceutical products. The company focuses on the progress of oral care, dermatology, and dietary supplements. BMG Pharma is committed to sustainability, diversity, and inclusion in the workplace. BMG Pharma has developed the hyaluromimethic® technology, which they believe is a fundamental value. The company has registered 36 innovative products and launched 37 on the international market. Recently, BMG Pharma has signed an agreement with HTL Biotechnology for the production of the functional ingredient at the base of the patented hyaluromimethic®. The company was founded in 2011 by Marco Mastrodonato and Roberto Bianchi, with Marco Mastrodonato serving as the CEO since then. | - |
Roberta Terpin | F | 46 |
BMG Pharma SpA
BMG Pharma SpA Household/Personal CareConsumer Non-Durables BMG Pharma SpA is a pharmaceutical company based in Milan, Italy. The Italian company specializes in the development and international partnership of bio-pharmaceutical products. The company focuses on the progress of oral care, dermatology, and dietary supplements. BMG Pharma is committed to sustainability, diversity, and inclusion in the workplace. BMG Pharma has developed the hyaluromimethic® technology, which they believe is a fundamental value. The company has registered 36 innovative products and launched 37 on the international market. Recently, BMG Pharma has signed an agreement with HTL Biotechnology for the production of the functional ingredient at the base of the patented hyaluromimethic®. The company was founded in 2011 by Marco Mastrodonato and Roberto Bianchi, with Marco Mastrodonato serving as the CEO since then. | 3 jaar |
Pietro Delogu | M | - |
Serichim Srl
Serichim Srl BiotechnologyHealth Technology Serichim Srl engages in research and development of chemical synthesis methods and processes for the production of fine chemical intermediaries. The firm's services include contract research, patent analysis, feasibility studies, consultancy and technical assistance, research and environmental consultancy, fermentation, enzyme fractionation, bioprocess engineering, pilot-scale and industrial processes. The company was founded in 2006 and is headquartered in Torviscosa, Italy. | - |
Alfonso Nardelli | M | - |
Serichim Srl
Serichim Srl BiotechnologyHealth Technology Serichim Srl engages in research and development of chemical synthesis methods and processes for the production of fine chemical intermediaries. The firm's services include contract research, patent analysis, feasibility studies, consultancy and technical assistance, research and environmental consultancy, fermentation, enzyme fractionation, bioprocess engineering, pilot-scale and industrial processes. The company was founded in 2006 and is headquartered in Torviscosa, Italy. | - |
Annalisa Cavalli | F | - |
BMG Pharma SpA
BMG Pharma SpA Household/Personal CareConsumer Non-Durables BMG Pharma SpA is a pharmaceutical company based in Milan, Italy. The Italian company specializes in the development and international partnership of bio-pharmaceutical products. The company focuses on the progress of oral care, dermatology, and dietary supplements. BMG Pharma is committed to sustainability, diversity, and inclusion in the workplace. BMG Pharma has developed the hyaluromimethic® technology, which they believe is a fundamental value. The company has registered 36 innovative products and launched 37 on the international market. Recently, BMG Pharma has signed an agreement with HTL Biotechnology for the production of the functional ingredient at the base of the patented hyaluromimethic®. The company was founded in 2011 by Marco Mastrodonato and Roberto Bianchi, with Marco Mastrodonato serving as the CEO since then. | - |
Claudio Alì | M | - |
BMG Pharma SpA
BMG Pharma SpA Household/Personal CareConsumer Non-Durables BMG Pharma SpA is a pharmaceutical company based in Milan, Italy. The Italian company specializes in the development and international partnership of bio-pharmaceutical products. The company focuses on the progress of oral care, dermatology, and dietary supplements. BMG Pharma is committed to sustainability, diversity, and inclusion in the workplace. BMG Pharma has developed the hyaluromimethic® technology, which they believe is a fundamental value. The company has registered 36 innovative products and launched 37 on the international market. Recently, BMG Pharma has signed an agreement with HTL Biotechnology for the production of the functional ingredient at the base of the patented hyaluromimethic®. The company was founded in 2011 by Marco Mastrodonato and Roberto Bianchi, with Marco Mastrodonato serving as the CEO since then. | - |
Relatiegrafiek
Connectie in verschillende bedrijven
Oude connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
Antonio Zambon | M | 57 |
TitanMet Private Equity
TitanMet Private Equity Investment ManagersFinance TitanMet SpA Private Equity, is the private equity operating division of Kyklos Spa and it manages the publicly listed investment vehicle TitanMet SpA (BIT:TTT). The firm was previously known as Sintesi Societa' di investmenti e Partecipazioni SpA and was founded in 1900 as Broggi Izar Fabbriche Riunite SpA. The firm is headquarterd in Milan Italy. | 4 jaar |
Statistieken
Land | Connecties | % van het totaal |
---|---|---|
Italië | 11 | 100.00% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- Roberto Bianchi
- Persoonlijk netwerk